The global photoacoustic imaging market size is expected to be valued at US$ 121.2 million in 2026 and projected to reach US$ 178.2 million by 2033, growing at a CAGR of 5.7% between 2026 and 2033.
The growth is driven by the rising burden of cancer and cardiovascular diseases, growing preference for non-ionizing and hybrid imaging, and increasing use of high-resolution functional imaging in preclinical and translational research. Clinical adoption is further supported by advances in laser sources, ultrasound detection, and contrast agents, as well as growing validation of photoacoustic imaging in peer-reviewed oncology, neurology, and vascular imaging studies.